Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with knowledge of the matter said, as takeovers of healthcare assets continue to defy the global dealmaking slump.
To read the entire story, you must be logged in.
Please log in now or register with us.
